Chlamydia pneumoniae is a respiratory pathogen associated with chronic inflammatory diseases such as asthma and atherosclerosis, and its detection in human carotid and coronary atheroma suggests some support for its involvement in atherogenesis. The main objective of our study was to evaluate the association between Chlamydia pneumoniae and atherosclerosis in Moroccan patients through a case-control approach and detected strain genotyping. A total of 137 cases and 124 controls were enrolled, nested PCR was performed for Chlamydia pneumoniae screening of the peripheral blood mononuclear cells (PBMCs) of both cases and controls as well as atheroma plaques from 37 cases, and positive samples were subjected to sequencing for genotyping and phylogenetic analysis. The results showed 54% and 18%, respectively, for positivity in cases and control PBMCs and 86.5% in atheroma plaques, the difference being significant between the two groups (P < 0.001, OR a = 8.580, CI, 95% [3. 273-22.491]). Strain sequence analyses showed more than 98% similarity with human reference strains, and revealed various genotypes. This study supports the involvement of Chlamydia pneumoniae in atherosclerosis in the studied population and genotyping revealed that detected strains were identical to human strains circulating worldwide.
INTRODUCTION
Chlamydia pneumoniae is a Gram-negative and intracellular bacterium, originally described as a human pathogen associated with pneumonia, sinusitis and pharyngitis (Grayston 1992) , and its involvement in cardiovascular diseases development was widely reported (Campbell and Kuo 2004; Sessa et al. 2007; Campbell and Rosenfeld 2015) . Saikku et al. (1988) were the first to associate C. pneumoniae with atherosclerosis, as specific antibodies were detected during the screening for probable infectious agents in patients with coronary heart disease and myocardial infarction. Chlamydia pneumoniae can play a role in the pathogenesis of atherosclerosis due to its ability to disseminate systemically from the lungs through peripheral blood mononuclear cells (PBMCs) and to localise in extrapulmonary sites such as the vascular wall (Moazed et al. 1998; Watson and Alp 2008) . Once inside the vascular tissue, C. pneumoniae has been shown to induce endothelial dysfunction and lowdensity lipoprotein (LDL) oxidation, resulting in the accelerated uptake of cholesterol by macrophages and the subsequent foam cell formation, which are considered the hallmark of early atherosclerotic lesions (Kalayoglu et al. 1999; He et al. 2009) . Chlamydia pneumoniae has also been demonstrated to contribute to platelet adhesion and aggregation, smooth muscle cell proliferation and migration, which are responsible for the progression and rupture of vascular lesions (Di Pietro et al. 2013; Chatzidimitriou et al. 2014) . Chlamydia pneumoniae was primarily considered as a human-specific pathogen (Saikku et al. 1992 ), but several studies have since shown that C. pneumoniae strains are also present in a range of animals, including horses (Storey et al. 1993) , koalas (Wardrop et al. 1999; Bodetti and Timms 2000) , reptiles and amphibians (Berger et al. 1999; Reed et al. 2000; Bodetti et al. 2002) . Human C. pneumoniae isolates were found to be almost identical to each other, with only 0.1% difference in 16S rRNA gene and 0.4% difference in the outer membrane protein A gene (ompA) (Bodetti et al. 2002) . While some of the animal isolates are almost identical to human strains, others seem to be genetically more diverse, with up to 6% ompA gene dissimilarity (Bodetti et al. 2002) .
Atherosclerosis constitutes a real public health problem in our country, but the involvement of C. pneumoniae in the disease is not sufficiently investigated and data related to this problem are scarce. The main objective of this study was to evaluate the association between C. pneumoniae infection and atherosclerosis in Moroccan patients through a case-control study and the genotyping of the C. pneumoniae detected strains.
MATERIALS AND METHODS

Patients and sampling
A total of 137 patients and 124 controls were balanced as much as possible in terms of gender and age (±3 years) and admitted respectively in cardiovascular surgery and ophthalmology departments at the university hospital, Ibn Rochd, Casablanca, Morocco. Clinical and behavioural data (family history of atherosclerosis, diabetes, arterial hypertension, triglyceride, total cholesterol, high-density lipoprotein (HDL), LDL, leukocytosis, tobacco and alcohol use) were completely recorded, and blood samples were collected in EDTA tubes after the patient's consent was obtained. In addition, 37 atheroma plaques were obtained from patients subjected to surgery. This study was approved by the institutional ethics committee.
DNA isolation, molecular screening and sequencing
After blood collection, PBMCs were isolated by Ficoll-Paque gradient and DNA extraction was performed by phenol/chloroform method (Mahony et al. 2000) . For DNA amplification, a first nested PCR was used for screening, and performed using HL1/HR1 as outer primers and IN1/IN2 as inner ones (Maass et al. 1997) . The PBMCs and atheroma plaque positive samples were reamplified by a second nested PCR using Cpn5P/Cpn3P and Cpn5N/Cpn3N primers, which target a 366-bp fragment of the VD4 region of the ompA gene for strains genotyping as described previously (Bodetti and Timms 2000) , as the maximum variability between Chlamydia pneumoniae isolates has been reported in this region (Wardrop et al. 1999) . For both rounds, DNA was amplified in 25 μl volume, containing 0.5 mM of primers, 200 mM desoxyribonucleotides, 1x PCR buffer, 1.2 U Taq polymerase (Go Taq, Promega) and 1 μl DNA sample in the first round and the PCR product in the second round. Each PCR assay was run in conjunction with positive and negative controls. The PCR was performed in the Biorad thermocycler (S1000 Thermal Cycler) with cycling conditions for both rounds as follows: one cycle at 95
• C for 3 min and 35 cycles at 94
• C for 30 s, 60
• C for 1 min and 72
• C for 1 min, followed by strand elongation at 72
• C for 10 min. PCR products were visualised by electrophoresis on 1.5% agarose gel. A total of 103 positive PCR products (60 PBMCs and 29 atheroma plaques from cases and 14 PBMCs from controls) were sequenced in both directions (sense and antisense strands) with Cpn5N/Cpn3N primers (Bodetti and Timms 2000) , using BigDye Terminator Chemistry in an ABI 3730xl automatic capillary DNA sequencer. BioEdit software was used for chromatogram correction, leading to 294 bp sequences after discarding both 5 and 3 primer ends.
Sequence analyses
Sequence similarity search was carried out with the blastx. algorithm (Altschul et al. 1997 ) against the non-redundant (nr) protein sequence database restricted to C. pneumoniae coding sequences, and gathered nucleotide sequences were aligned together with the 103 sequenced ones using MUSCLE (Edgar 2004 ). The multiple sequence alignment was restricted to the aligned characters corresponding to our VD4 regions, and identical regions were clustered into 22 distinct ones. Phylogenetic reconstruction was performed from these 22 aligned sequences by PhyML (Guindon and Gascuel 2003; Guindon et al. 2010) with evolutionary model GTR+ 4+I. The inferred tree was rooted by using three non-C. pneumoniae homologous sequences as an outgroup (accession numbers AB284066, KP165541, KP165540).
Statistical analysis
Statistical analysis was conducted using SPSS software, version 20.0. Data were recorded as the means ± standard deviation (SD) for continuous variables and as proportions for dichotomous variables. The chi-square test was used for group comparisons of proportions. Conditional logistic regression was used to estimate the odds ratio (OR) for matched case-control pairs before and after adjustment for potential confounders. For all comparisons, P < 0.05 was considered statistically significant.
RESULTS
Case and control characteristics comparison revealed male sex predominance in both of the groups, the age group between 56 and 65 years was more affected by atherosclerosis in the cases group, a significant difference between cases and controls in pathological (diabetes, arterial hypertension, triglyceride, total cholesterol, HDL and LDL) and behavioural risk factors (tobacco and alcohol use) was found (P < 0.001) and no family history of atherosclerosis was revealed (Table 1) . The molecular detection of Chlamydia pneumoniae by nested PCR revealed 54% (75/137) positive cases in PBMCs and 86.5% (31/37) in atheroma plaques. Whereas in the controls group, only 18% subjects were shown positive in PBMCs, the difference between C. pneumoniae prevalence in cases and controls was statistically significant (P < 0.001, OR = 5.776), suggesting that patients with C. pneumoniae infection are 5.7 times more likely to suffer from atherosclerosis ( (Table 3) . Strain genotyping was performed by sequencing the VD4 region of the ompA gene, as the maximum variability between C. pneumoniae isolates has been reported in this region (Wardrop et al. 1999) . A total of 103 positive samples in PBMCs (n = 60) and atheroma plaques from cases (n = 29) and PBMCs from controls (n = 14) were subjected to sequencing. The results showed a perfect identity (100%) between PBMC and atheroma plaque sequences belonging to the same subject. Following Cochrane et al. (2005) notations, VD4 region of the ompA gene could be classified into five genotypes: CpnA, CpnB, CpnC, CpnD and CpsK (see Table S1 , Supporting Information). However, sequence similarity searches against the nr databank (i.e. non-redundant set of coding sequence translations; NCBI Resource Coordinators, 2016) restricted to C. pneumoniae coding sequences have led to the discovery of a new genotype corresponding to C. pneumoniae isolate DC9 (Fig. 1) .
As expected, since CpnA is the most common worldwide genotype (see Table S1 ), it was retrieved in the majority of our samples, i.e. 47 PBMCs and 25 atheroma plaques' (denoted Ga in Table 4 , accession number KY086261). However, multiple sequence alignment revealed different single nucleotide polymorphisms (SNPs) at different positions in 13 PBMCs and four atheroma plaque sequences (Fig. 1) leading to new genotypes denoted G b (1 SNP; 11 new genotypes Gb1-Gb11, accession numbers respectively: KY086262, KY086263, KY086264, KY086265, KY086266, KY086267, KY086268, KY086269, KY086270, KY086271 and KY086272), G c (2 SNPs; 4 new genotypes Gc1-Gc4, accession numbers respectively: KY086273, KY086274, KY086275 and KY086276) and G d (4 SNPs; 1 new genotype, accession number KY086277); see Table 4 and Fig. 1 .
The phylogenetic analysis of the 22 distinct C. pneumoniae VD4 regions was performed, revealing that the detected (i.e. Ga, Gb1-Gb11, Gc1-Gc4 and Gd) and human reference (CpnA, CpnB and CpnC; see Table S1 ) strains made up a unique clade (Fig. 2) . Animal strains (CpnD, CpsK and DC9) made up a second distinct clade which is in accordance with the phylogenetic classification of the associated hosts, i.e. mammal hosts (CpnD and CpsK) are grouped together and clearly separated from the amphibia host (DC9).
DISCUSSION
Atherosclerosis is a complex multifactorial disease. Several studies showed that microbial agents may play an important role in this disease development. Atherosclerosis constitutes a real public health problem in Morocco. According to the World Health Organization, 40% of deaths in Morocco are due to heart disease (World Health Organization 2013). The main objective of this study was to evaluate the association between Chlamydia pneumoniae and atherosclerosis in Moroccan patients through Figure 1 . Codon sequence alignment of a 294-bp fragment of the ompA gene (VD4 region). Human reference CpnA genotype is used as reference sequence (represented with amino acid translation). A total of 22 distinct sequences are represented with dots when residues are identical to those of CpnA (see Table S1 for details about each genotype). Genotypes identified in this study are labelled Ga, Gb1-Gb11, Gc1-Gc4 and Gd. Underlined nucleotide triplets highlight SNPs leading to non-synonymous amino acid substitutions. a case-control study and strains genotyping. The most widely used method to identify C. pneumoniae infection is based on serological tests (Chatzidimitriou et al. 2009; Rostami et al. 2013) . In this study, we opted for molecular methodology, using nested PCR to detect the C. pneumoniae DNA in atheroma plaques of cases and in the PBMCs of cases and controls.
The results showed high C. pneumoniae prevalence in PBMCs of the cases group, with 54% versus 18% in controls, which is a significant difference assessed by statistical analyses. This study provides evidence of an association between C. pneumoniae infection and atherosclerosis in Moroccan patients. With the same goal, several studies have investigated the prevalence of C. pneumoniae DNA in atheroma plaques and PBMCs in cardiovascular disease patients and controls (Sessa et al. 2001 (Sessa et al. , 2003 Assar et al. 2016) . The Iranian study performed by Assar et al. (2016) revealed C. pneumoniae DNA in 30% cases' atheroma plaques versus 6% in Table 4 . Detected strains genotyping by differences at the omp A VD4 locus. controls; however, Sessa et al. (2001) found C. pneumoniae DNA in 72% of PBMCs in Italian patients versus 30.3% in controls. Both of these studies reported that C. pneumoniae infection was involved in atherogenesis. In addition, other serological studies confirmed this association (e.g. Huittinen et al. 2003; Arcari et al. 2005; Petyaev et al. 2010 , Azarkar et al. 2011 Rai et al. 2011) . However, some studies did not confirm the association between C. pneumoniae and atherosclerosis (Apfalter et al. 2004; Bossone et al. 2008) . Possibly, the difference between the reported prevalences can be related to geographical variations in the distribution of C. pneumoniae.
The multiple regression logistic model after co-factors exclusion showed a perfect association between C. pneumoniae and atherosclerosis (OR a = 8.580, CI, ). This result is in agreement with the hypothesis claiming that atherosclerosis development can be related to the bacterium's direct effect in the macrophage preparation on the absorption of oxidised LDL, which represents the first step in the atherogenesis process (He et al. 2009 ). Furthermore, arterial hypertension, diabetes and tobacco use were found as independent risk factors for atherosclerosis. Our results were in concordance with Badiaga et al. (2003) study, performed in France, which assessed a significant association between C. pneumoniae and coronary heart diseases (adjusted OR = 2.31, CI, 95% [1. 49-3.60] ).
The molecular analysis for strains genotyping targeting ompA gene VD4 region showed one dominant genotype (CpnA) that is identical to the human C. pneumoniae genotype previously published (Kalman et al. 1999; Read et al. 2000; Shirai et al. 2000) . The same C. pneumoniae genotype was identified by Cochrane et al. (2005) in Australian patients' atheroma plaques and PBMCs. In addition, we found two other genotypes in PBMCs, one showing only one SNP and the other with two SNPs at different positions; however, another genotype with four SNPs was detected in atheroma plaques. The SNPs' location in the detected genotypes makes them different from those reported in Cochrane's study, which presents sequence homology to non-human (frog/koala) genotypes (Cochrane et al. 2005; Kutlin et al. 2007) . Therefore, the genotyping of C. pneumoniae ompA gene showed minor polymorphisms in our C. pneumoniae strains.
CONCLUSION
Our case-control study confirms the involvement of Chlamydia pneumoniae in the atherosclerosis process in Moroccan patients; the molecular characterisation revealed that most Moroccan C. pneumoniae strains are identical to those circulating worldwide. However, new genotypes were also observed, some of them being characterised by non-synonymous SNPs.
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